• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol . Type I interferon signaling is required for resistance to primary influenza virus infection and vaccine-induced long-term immunity

tetano

Editor, Senior Moderator
J Virol


. 2026 Mar 27:e0022926.
doi: 10.1128/jvi.00229-26. Online ahead of print.
Type I interferon signaling is required for resistance to primary influenza virus infection and vaccine-induced long-term immunity

Ki-Hye Kim[SUP] 1 [/SUP], Hye Suk Hwang[SUP] 1 2 [/SUP], Surya Sekhar Pal[SUP] 1 [/SUP], Chau Thuy Tien Le[SUP] 1 [/SUP], Phillip Grovenstein[SUP] 1 [/SUP], Mahmuda Yeasmin[SUP] 1 [/SUP], Jae Min Song[SUP] 1 3 [/SUP], Young-Man Kwon[SUP] 1 4 [/SUP], Baozhong Wang[SUP] 1 [/SUP], Sang-Moo Kang[SUP] 1 [/SUP]


Affiliations
Abstract

Type I interferons (IFNs) are critical for early antiviral defense, yet their role in shaping vaccine-induced immunity remains incompletely understood. Here, we investigated the impact of type I IFN receptor (IFNαβR) deficiency on immune responses to influenza virus infection and vaccination in IFNαβR-deficient (AB6) mice. AB6 mice exhibited profound susceptibility to influenza virus infection, characterized by accelerated weight loss, elevated lung viral loads, and severe histopathology. Despite inducing short-term IgG antibodies and protection against weight loss after H5 hemagglutinin virus-like particle (H5 VLP) vaccination, AB6 mice were less effective in controlling lung viral loads and inflammation after lethal influenza virus infection, compared to the wild-type (B6) mice. IFNαβR deficiency dysregulated chemokines and numerous innate immune cells, particularly neutrophils, contributing to lung pathology after H5 VLP vaccination and influenza virus infection. AB6 mice exhibited a faster kinetics of waning IgG antibodies and lower efficacy of long-term protection after vaccination than wild-type B6 mice.IMPORTANCEType I interferons (IFNs) are essential mediators of antiviral defense, but their contribution to vaccine-induced immunity remains unclear. This study reveals that type I IFN receptor signaling is dispensable for the initial antibody induction but is critical for sustaining long-term humoral immunity and balanced immune regulation after influenza vaccination and infection. Loss of IFNαβR signaling leads to impaired viral control, excessive neutrophil-driven inflammation, and disrupted immune cell homeostasis. These findings highlight type I IFN signaling as a key integrator of innate and adaptive immune responses required for adequate and durable antiviral protection.

Keywords: durable immunity; influenza vaccine; neutrophils; type I IFN receptor.

 
Back
Top